Efficacy and safety of formoterol certihaler tiotropium handihaler and tiotropium handihaler in combination with formoterol certihaler in patients with stable chronic obstructive pulmonary disease.

Trial Profile

Efficacy and safety of formoterol certihaler tiotropium handihaler and tiotropium handihaler in combination with formoterol certihaler in patients with stable chronic obstructive pulmonary disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2011

At a glance

  • Drugs Formoterol; Tiotropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 24 Oct 2011 Actual end date (November 2005) added as reported by ClinicalTrials.gov.
    • 24 Oct 2011 Company Pacira Pharmaceuticals added to the associations filed as reported by ClinicalTrials.gov record.
    • 24 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top